Healthcare
Live Price
Offline$0.0002
+0.00% today
1Y Change
+100.00%
Window
Jun 20, 2025 → Jun 10, 2026
Coverage: 247 bars · Jun 20, 2025 → Jun 10, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
WellQuest Medical & Wellness Corporation (WEQL) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 100.0% across the available one-year price window (Jun 20, 2025 → Jun 10, 2026). Baseline metrics include revenue growth of -11.6%, EPS growth of -4.5%, a dividend yield of 0.0%. What stands out right now is revenue -11.6%, EPS -4.5%, free cash flow +83.6% with operating margin -6.3% and ROIC -23.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WEQL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WEQL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WEQL Max Drawdown
-93.44%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WEQL and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$4.2M
-2.2% YoY
FY Net Income
$891.1K
+380.2% YoY
Free Cash Flow
-$386.7K
+80.9% YoY
Revenue Growth
-11.6%
EPS Growth
-4.5%
Gross Margin
8.4%
Net Margin
-8.1%
Income statement
USD
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|
| Revenue | 5M | 6M | 5M | 4M | 4M |
| Gross Profit | 448K | 501K | 151K | 111K | 697K |
| Operating Income | -339K | -368K | -421K | -397K | 93K |
| EBITDA | -127K | -153K | -194K | -298K | 1M |
| Net Income | -436K | -423K | -332K | -318K | 891K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|
| Cash & Equivalents | 21K | 23K | 15K | 109K | 284K |
| Total Assets | 3M | 3M | 4M | 3M | 2M |
| Total Liabilities | 6M | 5M | 5M | 4M | 2M |
| Shareholder Equity | -2M | -2M | -1M | -1M | -744K |
| Total Debt | 4M | 4M | 4M | 3M | 1M |
| Net Debt | 4M | 4M | 4M | 3M | 873K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
12K
+110.9% YoY
Capital Expenditures
399K
+79.1% YoY
Free Cash Flow
387K
+80.9% YoY
Key ratios
Gross Margin
8.4%
Operating Margin
-6.3%
Net Margin
-8.1%
ROE
21.0%
Debt / Equity
-1.68x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.